Scarica l'app Stockscreener
10.27
12.67%
-1.49
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Ginkgo Bioworks Holdings Inc Azioni (DNA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
3.50%
20.16
|
19.47 | 33.40 | 38.84 | 49.60 |
| Cost Of Revenue |
44.51%
1.719
|
3.098 | - | - | - |
| Research and Development |
7.43%
46.21
|
49.92 | - | - | - |
| Costs And Expenses |
13.37%
78.70
|
90.85 | 114.79 | 119.59 | 110.19 |
| Depreciation and Amortization |
3.78%
12.31
|
12.80 | 13.66 | 14.17 | 15.79 |
| Operating Income/Loss |
17.97%
-58.55
|
-71.37 | -70.75 | -90.02 | -65.54 |
| Net Interest Income/Expense |
10.12%
3.232
|
3.596 | - | 5.742 | 6.083 |
| Income/Loss From Equity Method Investments |
-4.673
|
- | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
24.88%
-57.19
|
-76.14 | -81.39 | -80.75 | -60.58 |
| Income Tax Expense/Benefit |
260.00%
0.128
|
-0.08 | -0.643 | 0.001 | -0.283 |
| Income/Loss From Continuing Operations After Tax |
24.64%
-57.32
|
-76.06 | -80.75 | -80.75 | -60.30 |
| Income/Loss From Discontinued Operations, Net Of Tax |
262.55%
10.61
|
-6.528 | - | - | - |
| Net Income/Loss |
43.44%
-46.71
|
-82.59 | -80.75 | -80.75 | -60.30 |
| Basic Average Shares |
4.25%
62.09
|
59.56 | 0.5411 | 55.63 | 54.86 |
| Basic Earnings Per Share |
46.04%
-0.75
|
-1.39 | -1.42 | -1.45 | -1.10 |
5.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):